Home/Plasmology4/Greg Watson

GW

Greg Watson

Chief Innovation Officer

Therapeutic Areas

Wound Care Infectious Disease

Plasmology4 Pipeline

Drug	Indication	Phase
Plaz4 1000 System	Infected wounds, including those with multidrug-resistant bacteria (e.g., MRSA) and chronic (non-healing) wounds	Pre-clinical

Leadership Team at Plasmology4

Robert Hummel, MBA

Chief Executive Officer

Marc Jacofsky, PhD

Chief Scientific Officer

Emilia Kulaga, PhD

Senior Director of Research

View full Plasmology4 profile